Nutex Health (NASDAQ:NUTX) Stock Price Up 6.9% – What’s Next?

Nutex Health Inc. (NASDAQ:NUTX) shares traded up 6.9% on Monday. The company traded as high as $215.32 and last traded at $224.0050. Approximately 20,562 shares changed hands during trading, a decline of 88% from the average session volume of 166,768 shares. The stock had previously closed at $209.59.

Analysts Set New Price Targets

NUTX has been the subject of a number of recent research reports. LADENBURG THALM/SH SH assumed coverage on shares of Nutex Health in a research report on Monday. They issued a “buy” rating and a $336.00 target price for the company. B. Riley Financial reaffirmed a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. Zacks Research cut shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, October 3rd. Finally, Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $323.67.

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The company has a market cap of $1.45 billion, a P/E ratio of 8.33 and a beta of 0.55. The stock’s fifty day moving average price is $201.41 and its two-hundred day moving average price is $163.35.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. As a group, equities analysts predict that Nutex Health Inc. will post 27.58 earnings per share for the current year.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director owned 400 shares of the company’s stock, valued at approximately $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 44.68% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

A number of institutional investors have recently modified their holdings of the business. Kilter Group LLC bought a new stake in shares of Nutex Health during the 2nd quarter worth $27,000. Allworth Financial LP bought a new position in Nutex Health in the second quarter valued at about $35,000. GK Wealth Management LLC bought a new position in Nutex Health in the third quarter valued at about $73,000. EverSource Wealth Advisors LLC bought a new position in Nutex Health in the first quarter valued at about $83,000. Finally, State of Alaska Department of Revenue raised its stake in Nutex Health by 243.6% during the third quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company’s stock worth $211,000 after acquiring an additional 709 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.